Bruker pre-announces Q2 preliminary EPS $0.32-$0.34, down ~$0.19 YoY

BRUKER CORP

2025-Q2 EPS reported $0.16 revenue$1,598,800,000

Preliminary Q2 2025 revenue $795-$798M, roughly flat YoY reported; constant-currency revenue down ~3%.
Non-GAAP organic revenue declined ~7% YoY on weak academic demand and soft U.S. biopharma market.
Non-GAAP EPS expected $0.32-$0.34, down ~$0.19 YoY inclusive of $0.06 FX headwind.
Q2 2025 bookings reflect weak academic and biopharma demand; cost actions underway.
Final Q2 results and earnings call scheduled for August 4, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.